Anaptysbio, Inc Cash Flow Statement

Cash Flow Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.41M-4.26M-30.07M-61.66M-97.34M-19.93M-57.80M-128.72M-163.62M-145.23M
Share-based Compensation 0.60M1.16M4.38M9.96M12.41M11.50M15.35M27.36M33.20M34.05M
Gains from Investment Securities 1.28M0.76M1.37M-0.65M2.29M20.68M7.50M
Cash from Operations -9.69M-9.03M-19.44M-48.51M-69.52M-14.16M-45.92M-73.59M-120.80M-135.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M1.23M0.89M1.06M1.47M1.66M1.72M1.79M
Depreciation & Amortization (CF) 0.27M0.23M0.18M0.32M0.51M0.56M0.62M0.68M0.65M0.61M
Change in Working Capital
Change in Receivables -0.23M-0.00M-1.23M
Change in Accured Expenses 1.95M1.25M2.22M7.08M13.20M-7.69M-4.74M9.70M10.94M-33.84M
Change in Taxes 0.14M4.12M-2.52M-1.43M-0.17M
Other Working Capital Changes -9.08M-2.94M1.89M5.19M-3.58M-1.18M1.80M-1.50M4.19M-3.20M
Investing Activities
Capital Expenditures 0.24M0.10M0.29M1.06M0.81M0.57M1.37M0.36M0.81M0.36M
Sales of Property, Plant and Equipment 0.01M
Change in Acquisitions & Divestments 48.14M206.15M384.05M289.97M158.85M408.02M449.48M476.13M
Cash from Investing Activities -0.24M-0.05M-243.06M-142.45M131.43M94.47M38.84M-394.85M144.75M95.40M
Financing Activities
Other financing activities 1.45M1.15M1.60M0.18M0.49M
Cash from Financing Activities 39.40M8.63M292.45M223.36M-4.49M-0.88M252.30M44.02M-59.30M127.05M
Additional items
Change in Cash 29.47M-0.45M29.96M32.41M57.42M79.44M245.21M-424.42M-35.34M87.11M
Free Cash Flow -9.93M-9.13M-19.73M-49.57M-70.32M-14.73M-47.29M-73.95M-121.61M-135.69M
Net Cash Flow 29.47M-0.45M29.96M32.41M57.42M79.44M245.21M-424.42M-35.34M87.11M